News and Media
Releases
Using food molecules, the dietary pill reduces appetite and food cravings to promote healthy blood sugar regulation and sustainable weight loss
San Carlos, CA. Jan. 28, 2026---Northern California-based biotechnology company, Olfactive Biosolutions, has debuted PIVIT Weight Loss, a never-before-seen GLP-1 activator supplement made with all-natural ingredients to provide a safe alternative to prescription weight loss drugs.
Olfactive Biosolutions Welcomes Dr. Christopher Maclay as Chief Medical Officer
It’s Time to PIVIT® to Nature’s Weight Loss Signal
San Carlos, CA. August 2, 2025 -- Olfactive Biosolutions, the creator of the new, food molecule-based approach to healthcare, recently welcomed Dr. Christopher Maclay as our Chief Medical Officer.
MOUNTAIN VIEW, Calif.--Feb. 11, 2025--Olfactive Biosolutions, the leader in adapting food molecules to treat chronic diseases, was recently granted U.S. patent US 12,186,299 dated Jan. 7, 2025, Compositions And Methods For Treating Hypertension By Modulating Endocrine Activity, for its breakthrough food ingredient formulation that reduces high blood pressure. Pivit™ Blood Pressure can reduce blood pressure without the side effects and drawbacks of current pharmaceutical solutions, using food molecules from the FDA-approved GRAS (Generally Recognized as Safe) list.
MOUNTAIN VIEW, Calif.—January 14, 2025—Olfactive Biosolutions, the leader in adapting food molecules to treat chronic diseases, was recently granted a third patent for inducing the secretion of GLP-1 and GIP, in U.S. patent US 12,171,727 B1 dated Dec. 24, 2024, Compositions and Methods for Treating Endocrine Diseases and Disorders.
Related News
Featured on Military.com: Pivit, the All-Natural Weight Loss Alternative to Harsh GLP-1 Drugs
https://www.military.com/discounts/pivit-all-natural-weight-loss-alternative-harsh-glp-1-drugs
Olfactory Receptor OR51E1 Mediates GLP-1 Secretion in Human and Rodent Enteroendocrine L Cells
https://pmc.ncbi.nlm.nih.gov/articles/PMC6215084/
Olfactory Receptor OR51E1 Mediates GLP-1
Secretion in Human and Rodent
Enteroendocrine L Cells
https://pmc.ncbi.nlm.nih.gov/articles/PMC6215084/
A world on weight loss drugs: How GLP-1s are reshaping the economy
https://www.cnbc.com/2025/08/26/how-glp-1s-wegovy-zepbound-are-reshaping-the-economy.html
The $100 Trillion Disruption: Why GLP-1 Drugs, Not AI, Will Transform the Global Economy
https://wildfirelabs.substack.com/p/the-100-trillion-disruption-the-unforeseen
Ectopic OR1A1 activation ameliorates hepatic lipid deposition through AMPK/SREBP-1/FASN pathway by three monoterpenes
Journal of Functional Foods
https://www.sciencedirect.com/science/article/pii/S1756464624000999
Role of ectopic olfactory receptors in glucose and lipid metabolism
Natural Science Foundation of Zhejiang Province
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.15666
How smell regulates metabolism: The role of ectopically expressed olfactory receptors in lipid and glucose homeostasis
Journal of Translational Science, May 25, 2022
Human ectopic receptors and their food originated ligands: a review
Critical Reviews in Food Science and Nutrition, February 19, 2021
https://pubmed.ncbi.nlm.nih.gov/33605814/
Events
Military Veteran Startups Conference 2026 February 11-12, 2026 Marines' Memorial Club & Hotel, San Francisco, California
Natural Products Expo West March 3–6, 2026 Anaheim, California
IFT FIRST July 12–15, 2026 Chicago, IL
SupplySide Global October 29–30, 2026 Las Vegas, NV
For media inquiries please contact us at pr@olfactive.bio